Chengdu, China

Chunchi Liu

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chunchi Liu: Innovator in Pharmaceutical Chemistry

Introduction

Chunchi Liu is a notable inventor based in Chengdu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that can be used in medical treatments. His work focuses on innovative solutions for serious health conditions.

Latest Patents

Chunchi Liu holds a patent for a pyrazole compound, along with its preparation method and uses. The invention relates to a compound that can be utilized as a drug for treating cancer or fibrosis diseases. This patent highlights the potential of the compound in pharmaceutical applications, showcasing Liu's commitment to advancing medical science.

Career Highlights

Liu is associated with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., where he contributes to research and development efforts. His work at this company emphasizes the importance of innovation in biopharmaceuticals, aiming to improve patient outcomes through effective drug development.

Collaborations

Chunchi Liu collaborates with talented colleagues, including Qiang Tian and Yitao Zhang. These partnerships enhance the research environment and foster the exchange of ideas, which is crucial for successful innovation in the pharmaceutical industry.

Conclusion

Chunchi Liu's contributions to pharmaceutical chemistry, particularly through his patented pyrazole compound, demonstrate his dedication to improving healthcare solutions. His work at Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. and collaborations with fellow researchers further highlight the impact of innovation in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…